These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Analysis of oral suspensions containing sulfonamides in combination with erythromycin ethylsuccinate. Elrod L; Cox RD; Plasz AC J Pharm Sci; 1982 Feb; 71(2):161-6. PubMed ID: 6977637 [TBL] [Abstract][Full Text] [Related]
3. Bioinequivalence of erythromycin ethylsuccinate and enteric-coated erythromycin pellets following multiple oral doses. Yakatan GJ; Rasmussen CE; Feis PJ; Wallen S J Clin Pharmacol; 1985; 25(1):36-42. PubMed ID: 3871797 [TBL] [Abstract][Full Text] [Related]
4. Construction of universal quantitative models for determination of roxithromycin and erythromycin ethylsuccinate in tablets from different manufacturers using near infrared reflectance spectroscopy. Feng YC; Hu CQ J Pharm Biomed Anal; 2006 May; 41(2):373-84. PubMed ID: 16406447 [TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal side effects with erythromycin preparations. Carter BL; Woodhead JC; Cole KJ; Milavetz G Drug Intell Clin Pharm; 1987 Sep; 21(9):734-8. PubMed ID: 3498618 [TBL] [Abstract][Full Text] [Related]
6. Hepatotoxicity of erythromycin ethylsuccinate in a child. Phillips KG Can Med Assoc J; 1983 Sep; 129(5):411-2. PubMed ID: 6603894 [No Abstract] [Full Text] [Related]
9. [Stability of erythromycin stearate in coated tablets during the action of gastric juice in vitro]. Pospísilová B; Kubes J Cesk Farm; 1987 Mar; 36(2):67-72. PubMed ID: 3581192 [No Abstract] [Full Text] [Related]
10. [Acute hepatitis caused by erythromycin esters (propionate and ethylsuccinate)]. Paliard P; Stremsdoerfer N; Moindrot H Gastroenterol Clin Biol; 1983 Jan; 7(1):100-1. PubMed ID: 6601598 [No Abstract] [Full Text] [Related]
14. Hepatotoxic reaction to erythromycin ethylsuccinate. Patel J; Schneider R South Med J; 1984 Oct; 77(10):1343-4. PubMed ID: 6333077 [No Abstract] [Full Text] [Related]
15. Bioavailability and stability of erythromycin delayed release tablets. Ogwal S; Xide TU Afr Health Sci; 2001 Dec; 1(2):90-6. PubMed ID: 12789122 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of erythromycin ethylsuccinate after intragastric administration to healthy foals. Lakritz J; Wilson WD; Marsh AE; Mihalyi JE Vet Ther; 2002; 3(2):189-95. PubMed ID: 19750750 [TBL] [Abstract][Full Text] [Related]
17. [Hypothermia associated with erythromycin]. Cárdenes M; Artiles J; Arkuch A; Suárez S Med Clin (Barc); 1992 May; 98(18):715-6. PubMed ID: 1602886 [No Abstract] [Full Text] [Related]
18. [Hepatotoxicity of erythromycin]. García Buey L; García-Samaniego Rey J; González Estecha A; Pajares García JM Rev Clin Esp; 1989 Feb; 184(3):158. PubMed ID: 2785700 [No Abstract] [Full Text] [Related]
19. Fluorimetric determination of erythromycin and erythromycin ethylsuccinate in serum by a high-performance liquid chromatographic post-column, on-stream derivatization and extraction method. Tsuji K J Chromatogr; 1978 Oct; 158():337-48. PubMed ID: 721936 [TBL] [Abstract][Full Text] [Related]
20. Influence of food on absorption of erythromycin ethyl succinate. Thompson PJ; Burgess KR; Marlin GE Antimicrob Agents Chemother; 1980 Nov; 18(5):829-31. PubMed ID: 6969579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]